CTX.WA Stock — Price, Charts & Analysis

Captor Therapeutics Spolka Akcyjna (CTX.WA) has no trailing P/E shown and a forward P/E of -280.77x. This places CTX.WA in not enough valuation data territory based on the valuation data currently available on Worldtickers.

CTX.WA trades with -280.77x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether CTX.WA looks overvalued or undervalued.

CTX.WA's P/E of -280.77x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

CTX.WA's trailing EPS is -PLN 7.76 and forward EPS is -PLN 0.52.

EPS, or earnings per share, shows how much profit Captor Therapeutics Spolka Akcyjna generated for each share. CTX.WA's trailing EPS is -PLN 7.76, and investors usually prefer EPS that is positive and growing over time.

Captor Therapeutics Spolka Akcyjna has a market cap of PLN 462.34M, making CTX.WA a small-cap stock based on the current market value shown on Worldtickers.

CTX.WA's latest stock price on Worldtickers is PLN 73.00. The latest move is -PLN 0.20 or -0.27%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

CTX.WA's quote includes a latest price of PLN 73.00. The market open is PLN 73.70. Previous close is PLN 73.20. The intraday range is PLN 71.20 to PLN 73.70.

CTX.WA is down in the latest quote, with a move of -PLN 0.20 or -0.27%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

CTX.WA generated PLN 2.38M in trailing revenue. Revenue growth is -87.40%, which helps show whether demand is expanding or slowing.

CTX.WA's revenue growth is -87.40%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, CTX.WA does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -PLN 42.65M.

Gross margin is 75.99%. Margins show how efficiently Captor Therapeutics Spolka Akcyjna turns revenue into profit.

Captor Therapeutics Spolka Akcyjna carries PLN 3.19M and holds PLN 17.89M in cash.

CTX.WA holds PLN 17.89M on its balance sheet.

CTX.WA's book value per share is PLN 2.17.

Institutions hold 29.65% of CTX.WA shares. Insiders hold 29.31% of shares. Ownership mix helps investors understand how much of Captor Therapeutics Spolka Akcyjna is held by professional investors and company insiders.

CTX.WA has 6.33M shares outstanding. Float shares are 4.47M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for CTX.WA, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for CTX.WA is -PLN 0.52. Revenue growth is -87.40%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

CTX.WA's trailing EPS is -PLN 7.76. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

CTX.WA is in the Healthcare sector. Its earnings multiple is -280.77x. Its latest displayed growth metric is -87.40%. Compare these figures with sector peers before deciding whether Captor Therapeutics Spolka Akcyjna is stronger or weaker than average.

CTX.WA trades at PLN 73.00. The stock trades at -280.77x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Captor Therapeutics Spolka Akcyjna's fundamentals.

CTX.WA risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.55, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

CTX.WA should be compared with companies in Biotechnology. Its earnings multiple is -280.77x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Captor Therapeutics Spolka Akcyjna (CTX.WA) operates in Healthcare, specifically Biotechnology. Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, develops therapeutic molecules for treating oncological and autoimmune diseases in Poland. The company offers targeted protein degradation technology that utilizes the Optigrade drug discovery platform to overcome the limitations of inhibitors and antibody drugs by destroying disease-causing proteins that are resistant to available therapeutics. It develops viadrudomide, which is in a Phase 1 clinical trial for hepatocellular carcinoma (HCC), lung can

CTX.WA trades on Warsaw. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

CTX.WA stock is priced in PLN on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Captor Therapeutics Spolka Akcyjna's official website listed on Worldtickers is captortherapeutics.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Captor Therapeutics Spolka Akcyjna employs about 82 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Captor Therapeutics Spolka Akcyjna is headquartered in Wroclaw, Poland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

CTX.WA is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

CTX.WA has traded between PLN 33.00 and PLN 89.20 over the past 52 weeks. At PLN 73.00, it is 18.16% below the high and 121.21% above the low. The 52-week range helps gauge long-term price momentum.

CTX.WA is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is PLN 74.44 and its 200-day moving average is PLN 74.74.

CTX.WA's RSI is 50.00. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

CTX.WA's latest RSI reading is 50.00, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for CTX.WA is near PLN 67.20. Key resistance is near PLN 75.40. Breaks above resistance or below support can change the short-term technical setup.

CTX.WA's nearest reported support level is PLN 67.20. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

CTX.WA's nearest reported resistance level is PLN 75.40. A breakout above resistance can improve momentum, especially when volume confirms the move.

CTX.WA trades about 3.77K shares daily on average. The latest displayed volume is 792 shares. Volume helps show liquidity and whether trading interest is unusually high or low.

CTX.WA's MACD is 0.26, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

CTX.WA is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 50.00 (neutral). MACD is bullish. Nearest support is around PLN 67.20. Resistance is around PLN 75.40. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is PLN 72.49 (0.70% from price). MA50 is PLN 74.44 (-1.94% from price). MA200 is PLN 74.74 (-2.33% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. CTX.WA's MA20 is PLN 72.49. MA50 is PLN 74.44. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

CTX.WA's pivot is near PLN 72.07. Support is near PLN 67.20. Resistance is near PLN 75.40. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for CTX.WA is near PLN 67.20. The next upper resistance zone is near PLN 75.60. These levels help define risk and possible follow-through zones after a breakout or breakdown.

CTX.WA's Bollinger range is roughly PLN 69.29 to PLN 75.69. Band width is near 8.82%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

CTX.WA's ATR-based typical daily range is about 3.57%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 792 shares. Average volume is about 3.77K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

CTX.WA's all-time high shown on Worldtickers is PLN 209.00. Its all-time low is PLN 31.20. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

CTX.WA has a beta of 0.55, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.